HopeStage
Back to all studies
RecruitingNCT06799351

Gut microbiome during ozone treatment for chemotherapy-related nerve symptoms

About this titleRead the official source — NCT06799351
Medication studyAges 18+SpainAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

What will I do during this study?

This add-on observational study follows people already receiving chemotherapy and taking part in the OzoParQT trial. Depending on their assigned group, they receive usual care plus 40 rectal ozone or oxygen sessions over 16 weeks. The add-on study examines stool microbiome profiles alongside nerve symptoms and other outcomes.

Listed locations
Las PalmasSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 7, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
42
Sponsor
Bernardino Clavo, MD, PhD
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Spain
Age range
Over 18 Years
Official registry ID
NCT06799351
Official title
Show the full official title

Evaluation of the Gut Microbiome Profiles in Patients With Chemotherapy-induced Peripheral Neuropathy Treated in the Randomized Clinical Trial With Ozone OzoParQT (NCT06706544).

Recruitment & locations

Currently recruiting

Las Palmas

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Bernardino Clavo, MD, PhD.

Does this study involve medication?

Yes. The study involves medication, including Oxygen (placebo).

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies